In the last trading session, 4.57 million shares of the Capricor Therapeutics Inc (NASDAQ:CAPR) were traded, and its beta was 4.60. Most recently the company’s share price was $13.70, and it changed around $0.03 or 0.22% from the last close, which brings the market valuation of the company to $622.93M. CAPR currently trades at a discount to its 52-week high of $23.40, offering almost -70.8% off that amount. The share price’s 52-week low was $3.52, which indicates that the current value has risen by an impressive 74.31% since then.
Capricor Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended CAPR as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Capricor Therapeutics Inc (NASDAQ:CAPR) trade information
Instantly CAPR has showed a green trend with a performance of 0.22% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 16.17 on recent trading dayincreased the stock’s daily price by 15.28%. The company’s shares are currently down -0.72% year-to-date, but still down -13.29% over the last five days. On the other hand, Capricor Therapeutics Inc (NASDAQ:CAPR) is -8.91% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $15, which translates to bulls needing to increase their stock price by 8.67% from its current value. Analyst projections state that CAPR is forecast to be at a low of $10 and a high of $21.5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 30.59%.
CAPR Dividends
Capricor Therapeutics Inc’s next quarterly earnings report is expected to be released in April.
VANGUARD GROUP INC, with 4.9401% or 1.55 million shares worth $7.39 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.44 shares worth $19.71 million, making up 3.16% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 994.25 shares worth around $13.62 million, which represents about 2.19% of the total shares outstanding.
